Feb 11, 2026 07:31AM
Feb 11, 2026 07:30AM
Dec 3, 2025 08:32AM
Dec 3, 2025 08:30AM
Nov 25, 2025 08:30AM
Nov 12, 2025 07:30AM
Nov 6, 2025 08:30AM PolyPid's D-PLEX₁₀₀ Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year"
Nov 6, 2025 08:30AM
Sep 16, 2025 08:33AM
Sep 16, 2025 08:30AM
Aug 13, 2025 07:30AM
Jun 17, 2025 04:08AM
Jun 16, 2025 07:20PM
Jun 9, 2025 10:13AM PolyPid (PYPD) shares surge on successful D-PLEX100 trial results
May 14, 2025 07:00AM
Apr 14, 2025 06:54AM
Dec 26, 2024 06:35AM
Dec 23, 2024 07:22PM
Nov 13, 2024 07:00AM
Oct 2, 2024 06:47AM
Jun 10, 2024 07:00AM PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial
Aug 9, 2023 07:00AM
Jun 29, 2023 08:00AM
Jun 22, 2023 07:00AM
May 22, 2023 09:01AM
May 22, 2023 09:00AM
May 10, 2023 07:00AM
Feb 8, 2023 07:00AM PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Jan 24, 2023 07:05AM
Jan 24, 2023 07:00AM
Jan 3, 2023 07:02AM
Jan 3, 2023 07:00AM
Dec 12, 2022 07:06AM
Dec 12, 2022 07:00AM
Nov 9, 2022 07:00AM PolyPid Provides Corporate Update and Reports Third Quarter 2022 Financial Results
Oct 20, 2022 07:16AM
Oct 20, 2022 07:09AM
Sep 28, 2022 08:58AM
Sep 28, 2022 08:57AM
Sep 19, 2022 07:01AM
Sep 19, 2022 07:00AM
Sep 6, 2022 05:21AM UPDATE: Raymond James Downgrades PolyPid Ltd. (PYPD) to Outperform
Sep 2, 2022 09:11AM
Sep 2, 2022 08:37AM
Aug 10, 2022 07:00AM
Aug 3, 2022 07:00AM
May 31, 2022 07:04AM
May 31, 2022 07:00AM
May 23, 2022 07:03AM PolyPid Ltd. (PYPD) Reports Data Safety Monitoring Board Recommended to Conclude Enrollment of Phase 3 SHIELD I Trial of D-PLEX at the Minimum Number of Patients Targeted
May 23, 2022 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All